{
    "nctId": "NCT02685631",
    "briefTitle": "Yttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN Study",
    "officialTitle": "Radiation-Emitting SIR-Spheres in Non-resectable (RESIN) Liver Tumor Patient Study",
    "overallStatus": "COMPLETED",
    "conditions": "Localized Non-Resectable Adult Liver Carcinoma",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 1653,
    "primaryOutcomeMeasure": "Response to treatment with Y90 microspheres either as mono therapy or as part of multidisciplinary management of their specific disease",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients receiving SIR-Spheres therapy to the liver for the first time.\n* Provision of written informed consent.\n* Age 18 and older.\n\nExclusion Criteria:\n\n1. Prior completion of Y90 therapy to the liver (SIR-Spheres, TheraSpheres, or any other liver-targeted therapy involving the use of radiation-emitting spheres).\n\n   -Patients who have received Y90 treatment in the past and who are returning for another Y90 treatment are ineligible, even if new areas are being targeted.\n2. Need for surrogate consent. Patients unable to consent on their own behalves are not eligible for this study.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}